- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06075316
Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS)
Study Overview
Detailed Description
Thoracic surgery patients are at high risk for severe complications post-surgery, such as respiratory failure, empyema, wound problems, and even mortality. Patients with complications may need readmission and invasive management. Usual care may not capture the symptoms of surgery complications. Well-designed remote monitoring of postoperative patients may enable early intervention and lower the risk of severe complications.
This study evaluates the implementation and effectiveness of perioperative electronic patient-reported outcomes (ePROs) monitoring in thoracic surgery patients. Previous studies demonstrated the feasibility of ePROs monitoring by thoracic surgery patients and providers. This study will explore barriers to implementation before real-world effectiveness studies.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Amanda Gentry
- Phone Number: (336) 655-7743
- Email: Amanda_gentry@med.unc.edu
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- Recruiting
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill
-
Contact:
- Amanda Gentry
- Phone Number: 919-966-3381
- Email: amanda_gentry@med.unc.edu
-
Contact:
- MPH
-
Principal Investigator:
- Gita Mody, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patients participating in ePRO monitoring must meet the following inclusion criteria to participate in this study:
- 18 years or older
- English or Spanish speaking
- Able to complete a web-based, telephonic (IVR), or CRA (or other IRB-approved research team member)-administrated symptom survey
- Planned to undergo major thoracic surgery (involving chest wall incisions and overnight admission)
- Discharged from the thoracic surgery service
- Discharged to home
Exclusion Criteria:
All patients meeting any of the following exclusion criteria at enrollment will be excluded from study participation:
- Not completing planned surgery within 3 months of obtaining informed consent
- Inability to understand English or Spanish
- Having undergone only minor thoracic surgery (e.g. bronchoscopy, cervical mediastinoscopy)
- Dementia, altered mental status, or any psychiatric condition determined by the thoracic surgery provider team that would prohibit the understanding or rendering of informed consent.
- Current incarceration
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: ePRO monitoring
Thoracic surgery patients will be enrolled in ePRO monitoring using web-based or telephone surveys.
|
Alerts will be sent to providers via email and/or the electronic medical record at pre-specified response thresholds.
Providers will be instructed to respond to and document the management of alerts per their clinical routine.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reach of ePRO monitoring
Time Frame: Months 4 through 6 after implementation of the study
|
Percentage of eligible thoracic surgery patients enrolling in ePRO monitoring.
|
Months 4 through 6 after implementation of the study
|
|
Adoption of ePRO monitoring
Time Frame: Months 4 through 6 after implementation of the study
|
Percentage of ePRO monitoring alerts sent that result in clinical action by providers within 1 week of delivery
|
Months 4 through 6 after implementation of the study
|
|
Patient-level Uptake
Time Frame: Months 4 through 6 after implementation of the study
|
the percentage of enrolled patients who participate in >=1 ePRO survey.
|
Months 4 through 6 after implementation of the study
|
|
Overall Reach of ePRO monitoring
Time Frame: End of study
|
Percentage of eligible thoracic surgery patients enrolling in ePRO monitoring.
|
End of study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complication Rate
Time Frame: Baseline through 30 days post-discharge
|
Percentage of participants with severe complications (Clavien-Dindo grade >=3)
|
Baseline through 30 days post-discharge
|
|
Emergency department visit at 30 days
Time Frame: Baseline through 30 days post-discharge
|
Percentage of participants with an emergency department visit
|
Baseline through 30 days post-discharge
|
|
Emergency department visit at 90 days
Time Frame: Baseline through 90 days post-discharge
|
Percentage of participants with an emergency department visit
|
Baseline through 90 days post-discharge
|
|
Readmission at 30 days
Time Frame: Baseline through 30 days post-discharge
|
Percentage participants readmitted to a hospital
|
Baseline through 30 days post-discharge
|
|
Readmission at 90 days
Time Frame: Baseline through 90 days post-discharge
|
Percentage participants readmitted to a hospital
|
Baseline through 90 days post-discharge
|
|
Mortality at 30 days
Time Frame: Baseline through 30 days
|
Percentage participants who died
|
Baseline through 30 days
|
|
Mortality at 90 days
Time Frame: Baseline through 90 days
|
Percentage participants who died
|
Baseline through 90 days
|
|
Patient Alert Rate
Time Frame: Baseline through 90 days
|
Percentage of all patients who trigger at least 1 alert.
|
Baseline through 90 days
|
|
Alert Rate
Time Frame: Baseline through 90 days
|
Percentage of all ePRO surveys that trigger an alert
|
Baseline through 90 days
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Gita Mody, MD, MPH, University of North Carolina, Chapel Hill
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LCCC 2141
- 1K23HL157765-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.